Does Ozempic change your body shape?

Yes, GLP-1 medications can change body shape because fat isn't lost uniformly. Most patients lose visceral (abdominal) fat first, followed by subcutaneous fat in the face, arms, buttocks, and thighs. The rate of loss varies by body region, which can temporarily create an uneven appearance. Over 12-24 months, body proportions typically normalize.

How do you prevent loose skin on Ozempic?

You can reduce loose skin severity by losing weight gradually (following proper titration schedules rather than rushing to higher doses), eating adequate protein (1.2-1.6g per kg daily), staying hydrated, doing resistance training to maintain muscle volume, and protecting skin from sun damage. Age, total weight lost, and genetics also play significant roles.

Is Ozempic butt permanent?

For most patients, Ozempic butt improves over time. Skin continues remodeling for 12-24 months after weight stabilizes. Targeted glute exercises (squats, hip thrusts, lunges) can rebuild muscle volume in the area. For persistent cases after weight stabilization, body contouring procedures are an option.

Does GLP-1 medication cause muscle loss?

GLP-1 medications cause some lean mass loss, as does any form of weight loss. However, research shows the proportion of lean-to-fat loss is similar to calorie-restricted diets — GLP-1s don't cause disproportionate muscle wasting. Much of the reported 'lean mass' loss is actually liver mass, water, and organ tissue, not skeletal muscle. Resistance training and adequate protein intake significantly reduce muscle loss.

Patient Guides

GLP-1 Body Changes: Ozempic Butt, Loose Skin, and What to Expect

Q: What is Ozempic butt?

Ozempic butt refers to a flattened, sagging appearance of the buttocks that some patients notice during significant weight loss on GLP-1 medications like semaglutide. It happens because the gluteal region loses subcutaneous fat quickly while the overlying skin hasn't yet contracted to match the reduced volume. It's not unique to Ozempic — it occurs with any form of rapid weight loss.

Q: Where do you lose fat first on Ozempic?

Most patients lose visceral (deep abdominal) fat first, which is why waist circumference often decreases before the scale changes dramatically. Subcutaneous fat loss follows, typically from the face and trunk before the extremities. Individual variation is significant — genetics, sex, age, and baseline fat distribution all influence where you lose fat and in what order.

Sarah ChenLead Health Editor

Reviewed by Dr. James Okafor, PharmDPharmD

Updated March 28, 2026

Fact CheckedPatient Verified

What is Ozempic butt? How GLP-1 medications change your body — loose skin, fat redistribution, muscle loss appearance, and evidence-based strategies to manage body composition changes.

Key Takeaways

Visceral (abdominal) fat goes first on GLP-1s; gluteal and thigh fat loss follows later.
'Ozempic butt' occurs when gluteal fat loss outpaces skin contraction — it is not unique to semaglutide.
Tirzepatide SURMOUNT-1 showed ~40% visceral fat reduction vs. ~25% subcutaneous fat reduction at highest dose.
Skeletal muscle loss is ~20% of total weight lost — comparable to calorie restriction alone, not disproportionate.
Resistance training 2-3x/week plus 1.2-1.6g protein per kg body weight daily preserves ~80% of lean mass.

On this page

Find your match

Answer a few questions and we’ll match you with the right provider and medication.

Take the Quiz →

Free · 2 min · No signup required

GLP-1 Body Changes: Ozempic Butt, Loose Skin, and What to Expect

If you've lost significant weight on a GLP-1 medication and noticed your body looks different in ways you didn't anticipate — a flatter butt, sagging skin, a face that seems gaunt — you're experiencing something the clinical trials measured but rarely discussed in patient-friendly terms.

These body composition changes are real, they're common, and they're not unique to GLP-1 medications. They happen with any form of significant weight loss. But the speed at which GLP-1s produce results means many patients encounter these changes before they understand what's happening or what they can do about it.

Here's what the evidence shows about GLP-1 body changes, what you can realistically control, and when these changes warrant a conversation with your doctor. Whether you're asking about Ozempic butt, GLP-1 loose skin, or how semaglutide affects body composition — this is the complete patient guide.

The Short Version

GLP-1 medications change your body shape because fat isn't lost uniformly. Visceral fat goes first, then subcutaneous fat from the face, trunk, buttocks, and limbs — at different rates.
"Ozempic butt" is real — rapid gluteal fat loss outpaces skin contraction, creating a flattened or sagging appearance. It improves over time and responds to targeted exercise.
Loose skin correlates with total weight lost and speed of loss, not the specific medication. Patients losing >20% body weight are at highest risk.
Much of the "muscle loss" concern is overstated. Research shows GLP-1s don't cause disproportionate muscle wasting compared to equivalent caloric restriction.
You can meaningfully influence outcomes with protein intake, resistance training, hydration, and proper titration pacing.

What body changes actually happen on GLP-1 medications?

When you lose 15-25% of your body weight over 12-18 months — as many patients do on semaglutide or tirzepatide — your body doesn't simply become a smaller version of its previous self. Several distinct changes occur simultaneously.

Fat Loss Is Not Uniform

The body doesn't shed fat evenly across all regions. Research consistently shows a predictable pattern:

Visceral fat (around organs) goes first. This is the metabolically active fat packed around your liver, intestines, and other organs. It's also the most dangerous fat, which is why GLP-1 medications produce cardiovascular and metabolic benefits even before dramatic scale changes. Waist circumference often decreases notably within the first 2-3 months.
Subcutaneous trunk fat follows. The layer of fat under your skin around the abdomen, chest, and back decreases next.
Face, buttocks, arms, and thighs lose fat later — and at different rates. This uneven timing is what creates the "new body shape" many patients notice.

The SURMOUNT-1 trial (tirzepatide) measured body composition changes using DEXA scans and found that patients lost approximately 33% of their total fat mass at the highest dose, with visceral fat decreasing proportionally more than subcutaneous fat. This preferential visceral fat loss is actually a significant health benefit — but it means the visible changes lag behind the metabolic improvements.

Skin Doesn't Keep Up

Your skin has remarkable elasticity, but it has limits. When fat volume decreases faster than skin can contract, excess skin is the result.

Several factors determine severity:

Factor	Higher Risk	Lower Risk
Total weight lost	>20% body weight	<15% body weight
Speed of loss	>1.5 lbs/week sustained	Gradual titration
Age	Over 50	Under 35
Skin quality	Sun-damaged, smoking history	Well-maintained
Prior weight history	Multiple gain-loss cycles	First significant loss
Genetics	Less elastic skin type	More elastic skin type

The areas most commonly affected by loose skin during GLP-1 weight loss are the abdomen, upper arms, inner thighs, and buttocks. These regions have thinner skin and less structural support than areas like the back or chest.

Important context: skin remodeling continues for 12-24 months after weight stabilizes. Many patients who are distressed by loose skin at 6 months see meaningful improvement by 18 months. This is not a decision point for surgical intervention.

Body Proportions Shift

Patients frequently report that their body "looks different" beyond just being smaller. This happens because:

Fat distribution is partly genetic and hormonal. When you lose fat and regain some, it doesn't always return to the same locations.
Muscle-to-fat ratio changes. Even modest muscle loss combined with significant fat loss can make certain areas look different — more angular, less padded.
Postural changes. Carrying less weight changes how you stand, sit, and move, which affects how your body looks in ways that aren't about fat or muscle at all.

What is Ozempic butt and why does it happen?

"Ozempic butt" is a social media shorthand for the flattened, deflated, or sagging appearance of the buttocks that some patients notice during GLP-1 weight loss. The term is somewhat misleading — this isn't caused by semaglutide specifically, and it happens with any form of significant weight loss.

The Anatomy

The buttocks get their shape from three structures:

Gluteal muscles (gluteus maximus, medius, and minimus) — the deep foundation
Subcutaneous fat — the layer between muscle and skin that provides volume and contour
Skin — the outer envelope

When you lose weight on a GLP-1, the subcutaneous fat layer in the gluteal region decreases. If the overlying skin doesn't contract at the same rate (and it usually doesn't), the result is a flatter, less rounded appearance. In patients with significant weight loss, the skin may also sag.

Who Gets It

Not everyone on a GLP-1 develops noticeable gluteal changes. Risk factors include:

Higher baseline BMI. More starting fat means more potential volume loss in the area.
Rapid weight loss. Faster loss gives skin less time to adapt.
Sedentary lifestyle. Without exercise, the gluteal muscles don't maintain volume to partially offset fat loss.
Age over 40. Skin elasticity decreases with age, and collagen production slows.
Female sex. Women typically store more subcutaneous fat in the gluteal region, so proportional changes are more visible.

What You Can Do About It

The most effective intervention is targeted resistance training. The gluteal muscles are large and respond well to progressive overload:

Exercises that build gluteal muscle volume:

Hip thrusts — the single most effective glute-building exercise. Start with bodyweight, progress to barbell.
Bulgarian split squats — targets the gluteus maximus and medius with a stretch component.
Romanian deadlifts — emphasizes the posterior chain including glutes and hamstrings.
Cable kickbacks and lateral band walks — isolation work for the gluteus medius, which contributes to upper-buttock roundness.

A 2024 study in the Journal of Strength and Conditioning Research found that twice-weekly targeted glute training produced measurable increases in gluteal muscle cross-sectional area within 12 weeks — enough to partially offset the volume loss from fat reduction.

Other strategies:

Adequate protein — gluteal muscles need amino acids for hypertrophy. Aim for 1.2-1.6g per kg body weight daily.
Don't rush titration — slower dose escalation means slower fat loss, giving skin more time to adapt.
Compression garments — some patients find these improve appearance and comfort during the transition period, though they don't affect underlying tissue remodeling.

For patients who achieve their goal weight and wait 12-18 months but still have persistent gluteal deflation, cosmetic options include fat transfer (Brazilian butt lift), gluteal implants, or Sculptra injections. These are elective procedures with their own risk profiles — discuss with a board-certified plastic surgeon if considering.

Who is at risk of loose skin on a GLP-1 medication, and what actually works?

Loose skin is the body change that causes patients the most distress, and it's also the one where expectations matter most. Let's be clear about what's realistic.

The Reality

If you lose more than 20% of your body weight, some degree of excess skin is likely — regardless of whether you lose it through GLP-1 medication, bariatric surgery, or lifestyle changes alone. This is a physics and biology problem, not a medication problem.

The bariatric surgery literature is instructive here: approximately 70% of patients who undergo gastric bypass (which produces similar weight loss to high-dose tirzepatide) develop excess skin that bothers them. About 20% pursue surgical skin removal.

Prevention Strategies (Evidence-Based)

No strategy completely prevents loose skin during major weight loss. But these approaches reduce severity:

1. Gradual weight loss through proper titration

The STEP trials showed that semaglutide produces most of its weight loss in the first 30-40 weeks, with a plateau around 60-68 weeks. Following the recommended titration schedule (starting at 0.25mg, increasing every 4 weeks) rather than jumping to higher doses gives your skin more time to contract with the underlying tissue.

2. Protein intake

Protein provides the amino acids needed for collagen synthesis — the structural protein that gives skin its elasticity and firmness. Collagen production declines with age and is further compromised by caloric restriction.

Protein target	Rationale
1.2-1.6g per kg body weight daily	Supports muscle preservation AND collagen synthesis
≥25-30g per meal	Maximizes muscle protein synthesis per feeding
Include collagen-rich sources	Bone broth, skin-on poultry, gelatin support dermal collagen

3. Resistance training

Muscle fills space. Patients who resistance train during GLP-1 treatment retain more lean mass, and that preserved muscle volume partially offsets the visual impact of fat loss. This won't prevent loose skin, but it reduces how severe it looks.

Read our full guide: GLP-1 and Exercise: Performance, Muscle, and Workout Tips

4. Hydration

Dehydrated skin loses elasticity. GLP-1 medications can reduce fluid intake alongside food intake (less food = less water content consumed). Aim for 2.5-3 liters of water daily, more if exercising.

5. Skin care

Sun damage is the single biggest external factor in skin elasticity loss. Use SPF 30+ daily. Topical retinoids (prescription tretinoin or OTC retinol) promote collagen synthesis and may modestly improve skin quality during weight loss, though evidence is limited for loose skin specifically.

When to Consider Surgical Options

Body contouring surgery (abdominoplasty, brachioplasty, thigh lift, etc.) is the only reliable treatment for significant excess skin. Most surgeons recommend:

Wait 12-18 months after weight stabilization before evaluating. Skin remodeling takes time.
Achieve and maintain goal weight for 6+ months. Further weight loss after surgery compromises results.
BMI under 30 at time of surgery for optimal outcomes and lower complication risk.

Insurance coverage for post-weight-loss body contouring varies. Functional issues (skin infections, rashes, hygiene problems) strengthen the case for medical necessity. Purely cosmetic concerns are typically not covered.

Do GLP-1 medications cause muscle loss? Separating fact from fear

"You're losing all your muscle" is one of the most common warnings about GLP-1 medications. The reality is more nuanced — and more reassuring — than social media suggests. The reality is more nuanced — and more reassuring — than social media suggests.

What the Data Actually Shows

Yes, you lose some lean mass on GLP-1 medications. But the headline numbers are misleading.

The commonly cited figure is that 25-40% of weight lost is "lean mass." But "lean mass" on a DEXA scan includes much more than skeletal muscle:

Liver mass — decreases significantly during weight loss, especially in patients with fatty liver disease
Water — lean tissue holds more water than fat; as you lose mass, water content drops
Organ tissue — kidney, heart, and other organ mass adjusts with body size
Connective tissue — tendons, ligaments, fascia

A 2026 study in Cell Reports Medicine found that actual skeletal muscle loss was approximately 20% of total weight lost — not dramatically different from caloric restriction alone. The remaining "lean mass" loss was predominantly liver mass and water.

Research from Massachusetts General Hospital confirmed that GLP-1 medications don't cause disproportionate muscle wasting compared to equivalent weight loss from lifestyle changes. The medication drives weight loss through appetite reduction and caloric restriction — the body composition changes follow the same pattern as any caloric deficit.

For the full evidence breakdown, read: GLP-1 and Muscle Loss: What Patients Need to Know

Why It Matters Anyway

Even though GLP-1 muscle loss isn't dramatically worse than diet-alone muscle loss, preserving muscle is still important:

Metabolic rate. Muscle tissue burns more calories at rest. Losing it makes weight maintenance harder.
Physical function. Strength, balance, and mobility depend on skeletal muscle.
Body appearance. Patients who preserve muscle look leaner at the same weight — muscle provides the "toned" appearance many patients want.
Older adults. Patients over 65 face sarcopenia risk, making muscle preservation especially critical.

The Two Interventions That Work

Resistance training 2-3x per week. Progressive overload (gradually increasing weight or reps) sends the signal to preserve and build muscle even during caloric deficit. This is the single most effective intervention.
Protein intake ≥1.2g per kg body weight daily. Spread across 3-4 meals, with ≥25g per meal. Leucine-rich sources (dairy, eggs, poultry, fish) are particularly effective for muscle protein synthesis.

The combination of both is significantly more effective than either alone. A study in patients undergoing semaglutide treatment found that those who did resistance training and met protein targets retained approximately 80% of their lean mass, compared to approximately 60% in sedentary patients with lower protein intake.

How does fat redistribution work on GLP-1 medications?

One of the less-discussed body changes on GLP-1 medications is the shift in where fat is distributed — not just how much you have.

Visceral vs. Subcutaneous Fat

GLP-1 medications preferentially reduce visceral fat — the deep, metabolically active fat surrounding your organs. This is the fat most strongly linked to cardiovascular disease, insulin resistance, and inflammation.

Clinical trials consistently show that the ratio of visceral to subcutaneous fat loss favors visceral reduction. In SURMOUNT-1, visceral adipose tissue decreased by approximately 40% in the highest tirzepatide dose group, compared to roughly 25% reduction in subcutaneous fat.

This is excellent for your health. But it means the visible changes (subcutaneous fat that you can see and feel) don't fully reflect the metabolic improvements happening internally.

Regional Variation

Patients commonly report:

Abdomen/waist loses fat first — often the first visible change, driven by visceral fat reduction
Face loses fat noticeably — see our Ozempic Face Guide for a detailed discussion
Buttocks and thighs lose fat later — and the loss is more visible due to skin laxity
Upper arms and "bra fat" areas — common areas for noticeable change in women

Individual variation is significant. Genetics, sex, hormonal status, age, and baseline fat distribution all influence where you lose fat and in what order. Two patients at the same starting weight on the same dose can have visibly different body composition changes.

Does Fat Come Back in Different Places?

This is a common concern, and the answer is: potentially, yes.

After bariatric surgery, some studies have shown that regained weight can deposit in different locations than the original fat distribution. The data for GLP-1 medications specifically is limited, but the mechanism would be similar — fat cell dynamics change after significant weight loss.

If you stop a GLP-1 medication, studies show that approximately two-thirds of lost weight is regained within one year. The fat that returns may not distribute identically to your pre-treatment pattern. This is another reason why most clinicians now view GLP-1 treatment as long-term rather than a short course.

What are the best body recomposition strategies while on a GLP-1 medication?

Body recomposition — losing fat while maintaining or building muscle — is the goal that produces the best functional and aesthetic outcomes during GLP-1 treatment. Here is the evidence-based playbook. Here's the evidence-based playbook.

Nutrition

Protein first, always. With a reduced appetite, you have fewer calories to work with. Making protein the priority at every meal ensures you're supporting muscle preservation even when total food intake is lower.

Strategy	Target	Why
Protein per day	1.2-1.6g per kg body weight	Muscle preservation + collagen synthesis
Protein per meal	≥25-30g	Maximizes muscle protein synthesis
Protein timing	Within 2 hours post-exercise	Enhanced uptake by trained muscles
Leucine	≥2.5g per meal (found in dairy, eggs, meat)	Primary amino acid trigger for muscle building

Micronutrients matter too. Reduced food intake can create deficiencies that compound body composition problems:

Vitamin D — essential for muscle function. Many patients are deficient before starting GLP-1s.
Iron — critical for oxygen delivery to muscles during exercise.
Zinc — supports collagen synthesis and skin integrity.
Omega-3 fatty acids — may support muscle protein synthesis and reduce inflammation.

Ask your prescribing provider about a comprehensive metabolic panel and targeted supplementation.

Exercise Programming

The optimal exercise approach during GLP-1 treatment combines resistance training with moderate cardiovascular activity:

Resistance training (2-3x per week minimum):

Focus on compound movements: squats, deadlifts, bench press, rows, overhead press
Progressive overload: gradually increase weight, reps, or sets over time
Target all major muscle groups weekly
Don't avoid training on injection days — time your workouts when GI side effects are lowest (typically 3-5 days post-injection for most patients)

Cardiovascular exercise (150+ minutes per week):

Moderate intensity (brisk walking, cycling, swimming)
Supports cardiovascular health benefits of weight loss
Excessive cardio without resistance training can accelerate muscle loss — balance is key

Flexibility and mobility:

Body proportions changing can create new tightness patterns
Stretching and mobility work supports exercise quality and reduces injury risk

Timing and Patience

Body recomposition is slower than pure weight loss. During GLP-1 treatment:

Months 1-6: Focus on establishing exercise and protein habits. Accept that scale weight will decrease and body composition is in flux.
Months 6-12: Body shape begins to stabilize. Muscle definition becomes more apparent as fat continues decreasing.
Months 12-18: Weight typically plateaus. Skin remodeling continues. This is where consistent resistance training pays its biggest dividends.
Months 18+: Maintenance phase. If you've been training and eating adequate protein, this is when most patients report being happiest with their body composition.

When should you talk to your doctor about body changes on GLP-1 medication?

Most body composition changes during GLP-1 treatment are expected and manageable. But some warrant medical attention:

See your prescriber if:

You're losing more than 2 lbs per week consistently — dose adjustment may be appropriate
You feel significantly weaker or notice functional decline (difficulty with stairs, getting up from chairs)
You're eating less than 1,000 calories most days — nutritional counseling is needed
You notice unusual fat accumulation or redistribution patterns (could indicate hormonal issues)

See a dermatologist if:

Skin breakdown, rashes, or infections in skin fold areas
Significant hair loss (see: GLP-1 Hair Loss Guide)
Concerning changes to moles or skin texture

See a physical therapist or exercise physiologist if:

You're unsure how to start resistance training safely
You have joint issues that limit exercise
You want a personalized exercise program tailored to your GLP-1 treatment goals

Consider a plastic surgery consultation if:

You've been at stable weight for 12+ months
Excess skin is causing functional problems (chafing, hygiene issues, skin infections)
Excess skin is significantly affecting your quality of life
You have realistic expectations about surgical outcomes

How do you find a GLP-1 provider that supports body composition goals?

Not all telehealth GLP-1 providers address body composition. If body changes are a concern, look for providers that offer:

Body composition monitoring — DEXA scans or bioimpedance measurements, not just scale weight
Nutritional guidance — specifically protein targets and micronutrient support
Exercise integration — either direct programming or referrals to exercise professionals
Flexible titration — willingness to slow dose increases if weight loss is too rapid

Compare telehealth providers on our GLP-1 provider comparison page to find one that fits your needs.

What is the bottom line on GLP-1 body changes?

Body changes on GLP-1 medications are a feature of significant weight loss, not a unique side effect of the medication. Ozempic butt, loose skin, and visible muscle changes happen because your body is undergoing a major physical transformation.

The changes that bother patients most — loose skin, gluteal deflation, facial volume loss — are primarily driven by how much weight you lose and how quickly, not by which GLP-1 you take. The good news: the interventions that help (protein, resistance training, gradual titration, patience) are accessible to most patients and don't require expensive treatments.

Your body didn't get to its pre-treatment state overnight, and it won't settle into its new state overnight either. Give your skin 12-18 months to remodel after weight stabilization, stay consistent with nutrition and exercise, and have an honest conversation with your provider about any changes that concern you.

Frequently Asked Questions

What is Ozempic butt and is it permanent?

Ozempic butt refers to a flattened or sagging appearance in the gluteal region that occurs when subcutaneous fat is lost faster than the overlying skin can contract. It is not unique to semaglutide — it happens with any form of significant weight loss. For most patients it is not permanent. Skin continues remodeling for 12-24 months after weight stabilizes, and targeted glute exercises (hip thrusts, Bulgarian split squats, Romanian deadlifts) can rebuild muscle volume in the area. Surgical options exist for patients with persistent excess skin after weight stabilization.

How do you prevent loose skin while on semaglutide or tirzepatide?

There is no guaranteed prevention, but you can meaningfully reduce severity. Lose weight gradually by following the recommended titration schedule rather than rushing to higher doses. Eat adequate protein (1.2-1.6g per kg body weight daily) to support collagen synthesis. Do resistance training to maintain muscle volume. Stay well-hydrated — GLP-1 medications can reduce fluid intake alongside food. Protect skin from sun damage with SPF 30+. Patients who lose weight more slowly, maintain more muscle, and have better skin quality see less loose skin.

Does semaglutide cause muscle loss?

Yes, but less than the headlines suggest. The clinical trial data shows that approximately 25-40% of weight lost is "lean mass" — but lean mass includes liver mass, water, and organ tissue, not just skeletal muscle. Actual skeletal muscle loss is approximately 20% of total weight lost, which is comparable to calorie restriction alone. GLP-1 medications do not cause disproportionate muscle wasting. Resistance training (2-3x per week) and adequate protein intake (1.2-1.6g per kg daily) are the two most effective strategies to preserve muscle during treatment.

Where do you lose fat first on Ozempic or Wegovy?

Most patients lose visceral fat (around the organs, deep in the abdomen) first. This is why waist circumference often decreases before the scale shows major changes — and why GLP-1 medications produce significant cardiovascular and metabolic benefits early in treatment. Subcutaneous fat loss follows, typically from the face and trunk before the buttocks, thighs, and extremities. Individual variation is significant based on genetics, sex, age, and baseline fat distribution.

How long does it take for body changes to stabilize on GLP-1 medications?

Weight loss on GLP-1 medications typically plateaus at 60-68 weeks. Skin remodeling continues for 12-24 months after weight stabilizes. Body composition (the ratio of fat to muscle) continues improving with consistent resistance training even after the scale stops moving. Most patients report being happiest with their body composition at 18+ months — after excess skin has partially retracted, exercise habits are established, and any remaining loose skin is stable enough to evaluate for potential cosmetic intervention.

Does the face change on GLP-1 medications?

Yes — facial fat loss is common and can produce a gaunt or hollowed appearance that patients and observers sometimes call "Ozempic face." The face tends to lose subcutaneous fat relatively early in the weight loss process. For a detailed discussion of this specific change and options for addressing it, see our Ozempic Face Guide.

Ozempic Face: What It Is and What You Can Do — facial volume loss specifically
GLP-1 and Muscle Loss: What Patients Need to Know — deep dive into lean mass data
GLP-1 and Exercise: Performance, Muscle, and Workout Tips — exercise programming details
GLP-1 Side Effects by Medication — complete side effects comparison
GLP-1 Hair Loss Guide — another common body change concern

Sarah Chen

Lead Health Editor

Sarah covers telehealth and digital health access. She has spent 8 years in health journalism, previously writing for health policy publications. She leads editorial at Telehealth Ally.

Medically Reviewed By

Dr. James Okafor, PharmD

Dr. Okafor is a licensed pharmacist who reviews medication guides and dosing content for clinical accuracy. He has 12 years of experience in clinical pharmacy.

Related Comparisons

Amazon Clinic vs Ro Health for GLP-1 Weight Loss: Big Tech vs Dedicated Program

Amazon Clinic vs Ro Health for GLP-1: retail giant pharmacy access vs dedicated weight loss program. Pricing, clinical depth, and medication access compared. April 2026.

Eden Health vs Ro for GLP-1: 2026 Comparison

Eden Health vs Ro compared side-by-side — flat-rate compounded pricing vs brand-name medications, and which GLP-1 provider fits your situation in 2026.

eMed vs Ro for GLP-1 Weight Loss: 2026 Comparison

eMed vs Ro compared side-by-side — smart scale, video consultations, and adherence tech vs Ro's streamlined brand-name GLP-1 approach. Pricing, clinical model, and who each fits.

GLP-1 Body Changes: Ozempic Butt, Loose Skin, and What to Expect

Key Takeaways

GLP-1 Body Changes: Ozempic Butt, Loose Skin, and What to Expect

The Short Version

What body changes actually happen on GLP-1 medications?

Fat Loss Is Not Uniform

Skin Doesn't Keep Up

Body Proportions Shift

What is Ozempic butt and why does it happen?

The Anatomy

Who Gets It

What You Can Do About It

Who is at risk of loose skin on a GLP-1 medication, and what actually works?

The Reality

Prevention Strategies (Evidence-Based)

When to Consider Surgical Options

Do GLP-1 medications cause muscle loss? Separating fact from fear

What the Data Actually Shows

Why It Matters Anyway

The Two Interventions That Work

How does fat redistribution work on GLP-1 medications?

Visceral vs. Subcutaneous Fat

Regional Variation

Does Fat Come Back in Different Places?

What are the best body recomposition strategies while on a GLP-1 medication?

Nutrition

Exercise Programming

Timing and Patience

When should you talk to your doctor about body changes on GLP-1 medication?

How do you find a GLP-1 provider that supports body composition goals?

What is the bottom line on GLP-1 body changes?

Frequently Asked Questions

What is Ozempic butt and is it permanent?

How do you prevent loose skin while on semaglutide or tirzepatide?

Does semaglutide cause muscle loss?

Where do you lose fat first on Ozempic or Wegovy?

How long does it take for body changes to stabilize on GLP-1 medications?

Does the face change on GLP-1 medications?

Related Guides

Related Comparisons

Amazon Clinic vs Ro Health for GLP-1 Weight Loss: Big Tech vs Dedicated Program

Eden Health vs Ro for GLP-1: 2026 Comparison

eMed vs Ro for GLP-1 Weight Loss: 2026 Comparison

More Guides

Does Aetna Cover GLP-1 Medications? 2026 Coverage Guide

Aleniglipron: Structure Therapeutics' Oral GLP-1 — What Patients Need to Know

Amycretin (Zenagamtide): Novo Nordisk's Next-Gen GLP-1/Amylin Agonist

AOD-9604 for Weight Loss: Telehealth Providers Guide 2026

Best GLP-1 Medication 2026: Every Approved Option Ranked by Use Case

Which GLP-1 Has the Fewest Side Effects? A Medication-by-Medication Comparison

Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026

Best GLP-1 Pill Options in 2026: Oral Wegovy, Orforglipron & More

Best Oral GLP-1 Options 2026: Foundayo vs Rybelsus Complete Comparison

Best GLP-1 Under $200 Per Month: 2026 Budget Guide

Best GLP-1 Weight Loss Programs 2026: Every Major Provider Ranked

Best Growth Hormone Peptide Providers Online: 2026 Independent Comparison

Best Online HRT 2026: Telehealth Menopause Treatment Platforms Compared

Best Online TRT Clinics 2026: Telehealth Testosterone Replacement Compared

Best Oral GLP-1 Options in 2026: Every Pill Compared

Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care

Best Weight Loss Injection 2026: Wegovy HD, Zepbound, and Every Option Compared

Best Weight Loss Medication 2026: Every FDA-Approved Option Ranked

Does Blue Cross Blue Shield Cover GLP-1 Medications? 2026 Guide

Best BPC-157 Telehealth Providers 2026: Complete Guide

BPC-157 vs TB-500: Which Injury Recovery Peptide Is Right for You?

CagriSema Dosing Guide: Titration Schedule, Dose Steps & What to Expect

CagriSema Launch Day Patient Guide: What to Do Now That It's Here

CagriSema: The Semaglutide + Cagrilintide Combination — Patient Guide

CagriSema FDA Decision Guide: What to Expect and How to Prepare

CagriSema: What Patients Need to Know While the FDA Decision Drags On

CagriSema Side Effects: What Clinical Trials Show About Safety and Tolerability

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

Cheapest GLP-1 Without Insurance in 2026: Every Option Ranked by Price

CJC-1295 vs Ipamorelin: Complete Telehealth Comparison Guide 2026

CMS BALANCE Model Explained: Medicaid Obesity Care for 2026 and Beyond

Medicare GLP-1 Bridge Program: Implementation FAQ for Patients

Compounded GLP-1 Shutdown Timeline: From Shortage to Enforcement (2023–2026)

Is Compounded HRT Safe? What Patients Need to Know in 2026

Is Compounded Semaglutide Legal and Safe in 2026?

Compounded Tirzepatide 2026: What's Happening and What Patients Should Do